Clinical Trial Update: Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating apatinib in combination with S-1 as first-line therapy for advanced gastric cancer. The current status and results have not been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Qingdao Municipal Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN